 |  |  |  |  |  |  |  |
| | | | | | | |
|
|
Overcoming Barriers to Immune Therapy in MelanomaStatement of Educational NeedMelanoma affects 1 in 35 individuals during their lifetime. Immune-based therapies are being developed for metastatic melanoma, a form of the cancer for which excision of the melanoma lesions is ineffective. |
||||||||||
BioSymposia, Inc. is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Association's American Nurses Credentialing Center, and the Accreditation Council for Pharmacy Education. We also work with other key accreditors. This site contains medical information and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy. © 2008 BioSymposia, Inc., All rights reserved. |
|||||||||||
